| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| POLAREAN IMAGING Aktie jetzt für 0€ handeln | |||||
| 29.12.25 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 29.12.2025 | 1.954 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 29.12.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 29.12.2025ISIN NameAU0000111395 PROSPECH... ► Artikel lesen | |
| 23.12.25 | XFRA 8ZF: AUSSETZUNG/SUSPENSION | 368 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILPOLAREAN IMAG.LS-... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDTRONIC | 92,40 | -0,62 % | Medtronic: What Happens When Healthcare Technology Starts With People | From living rooms to operating rooms, human-centered design is informing the future of tech?Key takeawaysHuman-centered design at Medtronic uses patient, caregiver, and clinician insights to make medical... ► Artikel lesen | |
| HCA HEALTHCARE | 451,00 | 0,00 % | Nach der US-Wahl: Diese Aktien werden jetzt zu Gewinnern - deutsche Konzerne dabei | © Foto: wO-GeminiDer Wahlsieg der Demokraten verändert die Spielregeln an der Börse. Solaraktien schießen nach oben, auch Europas Industrie hofft auf Entlastung. Welche Unternehmen kurz- und langfristig... ► Artikel lesen | |
| LANTHEUS | 91,00 | -1,52 % | Lantheus Holdings, Inc.: Lantheus Presents Data from Two Pivotal Phase 3 Studies of TAUKLARIFY (Florquinitau F 18 Injection) PET Imaging in Early Alzheimer's Disease | ||
| CAREDX | 67,00 | -1,47 % | CareDx is a new Overweight at Piper Sandler on transplant testing opportunity | ||
| ENVISTA | 21,400 | 0,00 % | Here's Why You Should Retain NVST Stock in Your Portfolio for Now | ||
| GT BIOPHARMA | 3,150 | -0,94 % | GT Biopharma reports Q3 results | ||
| SYNEOS HEALTH | - | - | Research Solutions, Inc.: Research Solutions Reports Fourth Quarter and Fiscal Year 2026 Results | Reports Record Fiscal Year Net Income of $2.8 Million, 14% YoY B2B ARR Increase and ARR of $22.5 Million
HENDERSON, Nev., Sept. 9, 2026 /PRNewswire/ -- Research... ► Artikel lesen | |
| CARMAT | - | - | CARMAT SAS: EFICAS Study Results Confirm the Clinical Performance of the Aeson Total Artificial Heart as a Bridge-to-Transplant Therapy | The study's primary endpoint was achieved in 72.7% of the 55 patients implanted between December 2022 and May 2025.
This rate was significantly above the historical benchmark of 38% established... ► Artikel lesen | |
| CHEMOMETEC | 93,00 | +1,14 % | Chemometec A/S: Major shareholder announcement - BlackRock, Inc. | ||
| DEVYSER DIAGNOSTICS | 5,740 | -3,04 % | Devyser Diagnostics AB: Devyser Diagnostics AB publishes quarterly report for the period July to September 2026 | "Our direct sales markets continued to grow in the third quarter. Over the period, we also took important steps to strengthen the business ahead of 2027. We broadened our product portfolio, launched... ► Artikel lesen | |
| ARRAIL GROUP | 0,203 | -100,00 % | ARRAIL GROUP (06639): FURTHER DELAY IN PUBLICATION OF OUTSTANDING FINANCIAL RESULTS AND POSTPONEMENT OF ANNUAL GENERAL MEETING AND CONTINUED SUSPENSION ... | ||
| PROMIMIC | 0,730 | +0,69 % | Promimic AB Q2 Sales Increase | ||
| LIFESTANCE HEALTH GROUP | 14,170 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 69,84 | +0,01 % | BMO raises BrightSpring Health stock price target on LDD momentum | ||
| HEARTFLOW | 47,040 | -0,06 % | Heartflow stock tumbles despite strong growth beating Q3 expectations |